Sharp Edge Labs

About:

Sharp Edge Labs is engaged in the development of biosensors for cellular biology research and high-throughput screening.

Website: http://sharpedgelabs.com

Twitter/X: sharpedgelabs

Top Investors: Innovation Works, Newlin Investment Company

Description:

Sharp Edge Labs, Inc. engages in developing biosensors for cellular biology research and high-throughput screening. The company’s products include targeted biosensors to the cellular biology research community. It offers its products based on the fluorogenic activating proteins that provide a detection method for cellular changes, which is amendable to high-throughput screening and follow-up. The company was incorporated in 2011 and is based in Pittsburgh, Pennsylvania.

Total Funding Amount:

$4.6M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Pittsburgh, Pennsylvania, United States

Founded Date:

2010-01-01

Founders:

Alan Waggoner, Marcel Bruchez

Number of Employees:

1-10

Last Funding Date:

2019-08-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai